Investing Profile

Jonathan Silverstein

VCInvestor
Executive Partner at OrbiMed
orbimed.comNew York, New York
Photo of Jonathan Silverstein, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
32
$18B
CompanyStageDateRound SizeTotal Raised
Aspen Neuroscience
Series BMay 2022$150M
Series AApr 2020$70M
SeedDec 2019$7M
$230M
Co-investors: Peter Thompson (OrbiMed), Doug Fisher (InterWest), Sam Altman
AcureX Therapeutics
GrantAug 2021
Co-investors: Brian Fiske (Flagship Ventures)
NeuroPace
Series UnknownAug 2020$33M
Series UnknownOct 2017$74M
$190M
Co-investors: James Blair (Domain Associates)
Prevail Therapeutics
Series BMar 2019$50M
Series AMar 2018$75M
$130M
resTORbio
Series ANov 2017$40M
$40M
Audentes Therapeutics
Series COct 2015$65M
Series BDec 2014$43M
Series AJul 2013$30M
$140M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Jonathan Leff (Deerfield Management), Tom Woiwode (Versant Ventures)
Glaukos
Series FFeb 2013$30M
Series EFeb 2011$30M
Series DAug 2008$35M
$95M
Co-investors: Paul Madera (Meritech Capital Partners), Chau Khuong (OrbiMed), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Relypsa
Series UnknownOct 2012$3M
Series CAug 2012$80M
Private EquityJul 2012$62M
Series BAug 2011$70M
Series BSep 2010$70M
$290M
Co-Founder The Silverstein Foundation for Parkinson's with GBA2017 - Present
Co-Head of Private Equity and General Partner OrbiMed Advisors1999 - Present
University of San Diego Doctor of Law (JD) and MBA
Denison University Bachelor's degree Economics